Cherian Aleena Mary, Joseph John, Nair Manitha B, Nair Shantikumar V, Maniyal Vijayakumar, Menon Deepthy
Amrita Centre for Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Ponekkara P.O, Cochin, 682041 Kerala, India.
Department of Cardiology, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham, Ponekkara P.O, Cochin, 682041 Kerala, India.
ACS Omega. 2020 Jul 7;5(28):17582-17591. doi: 10.1021/acsomega.0c02045. eCollection 2020 Jul 21.
Bare metal stents (BMSs) of stainless steel (SS) were surface engineered to develop nanoscale titania topography using a combination of physical vapor deposition and thermochemical processing. The nanoleafy architecture formed on the stent surface remained stable and adherent upon repeated crimping and expansion, as well as under flow. This titania nanoengineered stent showed a preferential proliferation of endothelial cells over smooth muscle cells in vitro, which is an essential requirement for improving the in vivo endothelialization, with concurrent reduction of intimal hyperplasia. The efficacy of this surface-modified stent was assessed after implantation in rabbit iliac arteries for 8 weeks. Significant reduction in neointimal thickening and thereby in-stent restenosis with complete endothelial coverage was observed for the nanotextured stents, compared to BMSs, even without the use of any antiproliferative agents or polymers as in drug-eluting stents. Nanotexturing of stents did not induce any inflammatory response, akin to BMSs. This study thus indicates the effectiveness of a facile titania nanotopography on SS stents for coronary applications and the possibility of bringing this low-priced material back to clinics.
采用物理气相沉积和热化学处理相结合的方法,对不锈钢裸金属支架(BMS)进行表面工程处理,以形成纳米级二氧化钛形貌。支架表面形成的纳米叶状结构在反复卷曲和扩张以及流动条件下仍保持稳定且附着良好。这种二氧化钛纳米工程支架在体外显示出内皮细胞相对于平滑肌细胞的优先增殖,这是改善体内内皮化并同时减少内膜增生的一项基本要求。将这种表面改性支架植入兔髂动脉8周后评估其疗效。与BMS相比,即使不使用任何抗增殖剂或聚合物(如药物洗脱支架中所用的),纳米纹理化支架也观察到显著减少新生内膜增厚,从而减少支架内再狭窄,并实现完全内皮覆盖。支架的纳米纹理化不会像BMS那样引发任何炎症反应。因此,本研究表明了在不锈钢支架上进行简便的二氧化钛纳米形貌处理对冠状动脉应用的有效性,以及将这种低成本材料带回临床的可能性。